|
Matthew Loar joined NTI in April 2008. Mr. Loar is a Certified Public Accountant with over 20 years of experience in finance and accounting. He has a strong track record working with growing pharmaceutical and biotechnology companies, and has played a key role in several major corporate collaborations, successfully completing public and private equity financings and implementing the provisions of Sarbanes-Oxley Act at a public biotechnology company. Mr. Loar joined the company from Osteologix, where he served as Chief Financial Officer since 2006. Previously he was Chief Financial Officer at Genelabs Technologies. He graduated from the University of California, Berkeley and is a member of the American Institute of CPAs.
| 